These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


136 related items for PubMed ID: 4396059

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The immunosuppressive effects of adamantoyl cytarabine. II. Effects on skin allograft rejection by rats and mice.
    Gray GD, Mickelson MM.
    Transplantation; 1970 Feb; 9(2):176-8. PubMed ID: 4905927
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Prolongation of skin xenograft survival by L-asparaginase.
    Etheredge EE, Shons A, Harris N, Najarian JS.
    Transplantation; 1971 Mar; 11(3):353-4. PubMed ID: 4934269
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Improvement of the results of renal transplantation by the use of antilymphocyte globulin (ALG)].
    Renna E, Alfani D, Monari C, Trovati A, Berloco P, Famulari A, Cucchiara G, Cortesini R.
    Minerva Chir; 1980 May 31; 35(10):747-50. PubMed ID: 7005730
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Effect of immunosuppressive drugs on the transplantation immunology. I. Effect on the blastic reaction in the regional lymph nodes].
    Patkowski J.
    Postepy Hig Med Dosw; 1968 May 31; 22(6):911-56. PubMed ID: 4885890
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Experimental and clinical experiences with isonicotinoylhydrazone-d-glucuronic-acid-lactone (Gluronazid)].
    Meyer-Rohn J, Schmidt P.
    Hautarzt; 1971 Mar 31; 22(3):105-10. PubMed ID: 5553060
    [No Abstract] [Full Text] [Related]

  • 32. On the mode of action of some immunosuppressant drugs.
    Patkowski J.
    J Pharm Pharmacol; 1968 Dec 31; 20(12):957-9. PubMed ID: 4388341
    [No Abstract] [Full Text] [Related]

  • 33. Histidine decarboxylase inhibitors and second-set allograft survival.
    Moore TC.
    Arch Surg; 1969 Oct 31; 99(4):470-3. PubMed ID: 4897193
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Synergism in immunosuppression. 3. Allograft rejection and humoral antibody production in intact and splenectomized mice.
    Gelfand MC, Nowakowski A, Friedman EA, Knepshield JH.
    Transplantation; 1971 Nov 31; 12(5):377-83. PubMed ID: 4948689
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Survival of intestinal allografts in the dog with and without immunosuppression.
    Macalalad FV, Johnson HA, Apostol JV, Preston FW.
    Surg Forum; 1965 Nov 31; 16():224-5. PubMed ID: 5836067
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.